F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatic encephalopathy

Page 1 of 3 ( 101 items )
<<
1
2
3
>>

1	Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification 2/12/2026 11:20:20 AM \| Browse: 1 \| Download: 1
2	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 48 \| Download: 183
3	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 58 \| Download: 174
4	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 47 \| Download: 133
5	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 65 \| Download: 181
6	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 170 \| Download: 273
7	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 124 \| Download: 167
8	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 64 \| Download: 219
9	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 353 \| Download: 212
10	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 311 \| Download: 144
11	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 186 \| Download: 303
12	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 82 \| Download: 159
13	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 75 \| Download: 449
14	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 81 \| Download: 603
15	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 38 \| Download: 107
16	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 95 \| Download: 431
17	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 165 \| Download: 518
18	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 98 \| Download: 627
19	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 84 \| Download: 580
20	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 108 \| Download: 417
21	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 100 \| Download: 456
22	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 101 \| Download: 616
23	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 157 \| Download: 688
24	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 155 \| Download: 532
25	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 156 \| Download: 555
26	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 146 \| Download: 572
27	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 157 \| Download: 660
28	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 147 \| Download: 905
29	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 134 \| Download: 947
30	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 130 \| Download: 554
31	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 232 \| Download: 912
32	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 275 \| Download: 882
33	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 282 \| Download: 1047
34	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 252 \| Download: 873
35	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 306 \| Download: 759
36	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 288 \| Download: 823
37	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 443 \| Download: 1291
38	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 371 \| Download: 1130
39	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 481 \| Download: 1359
40	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 585 \| Download: 1433
41	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 636 \| Download: 1207
42	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 655 \| Download: 2272
43	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 652 \| Download: 2250
44	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 531 \| Download: 1367
45	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 554 \| Download: 1067
46	Simultaneous embolization of spontaneous porto-systemic shunts and intrahepatic arterioportal fistula: A case report 10/29/2021 12:16:54 PM \| Browse: 645 \| Download: 1827
47	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 829 \| Download: 1913
48	Neurological and psychiatric effects of hepatitis C virus infection 8/4/2021 7:56:20 AM \| Browse: 836 \| Download: 1896
49	Long-term albumin infusion in decompensated cirrhosis: A review of current literature 4/16/2021 10:13:42 AM \| Browse: 740 \| Download: 1706
50	Comparative study of the indocyanine green-R15, Child-Pugh score and model for end-stage liver disease score for the prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 1/29/2021 7:57:41 AM \| Browse: 793 \| Download: 2108

Page 1 of 3 ( 101 items )
<<
1
2
3
>>

1	Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification 2/12/2026 11:20:20 AM \| Browse: 1 \| Download: 1
2	Minimal hepatic encephalopathy in hepatosplenic schistosomiasis: High prevalence and association with portosystemic shunts in a Brazilian cross-sectional study 12/26/2025 10:27:29 AM \| Browse: 48 \| Download: 183
3	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 58 \| Download: 174
4	Elevated body mass index as a prognostic marker in acute liver failure: Implications from a two-decade cohort 12/5/2025 6:43:30 AM \| Browse: 47 \| Download: 133
5	Management of acute liver failure-an updated literature review 11/28/2025 2:00:44 PM \| Browse: 65 \| Download: 181
6	Improved clinical outcomes following embolization of extrahepatic portosystemic shunts in cirrhotic patients with recurrent hepatic encephalopathy 10/27/2025 10:57:51 AM \| Browse: 170 \| Download: 273
7	Microbiome and gut-liver interactions: From mechanisms to therapies 10/27/2025 8:08:12 AM \| Browse: 124 \| Download: 167
8	Body mass index and its association with clinical outcomes in acute liver failure 10/11/2025 9:30:02 AM \| Browse: 64 \| Download: 219
9	Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness 9/19/2025 7:57:22 AM \| Browse: 353 \| Download: 212
10	Paradigm shifts in hepatic encephalopathy: A review of recent therapeutic breakthroughs 9/10/2025 8:40:29 AM \| Browse: 311 \| Download: 144
11	Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview 8/27/2025 9:21:14 AM \| Browse: 186 \| Download: 303
12	Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders 8/26/2025 10:18:28 AM \| Browse: 82 \| Download: 159
13	Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi 7/18/2025 3:29:25 PM \| Browse: 75 \| Download: 449
14	Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update 6/26/2025 7:27:59 AM \| Browse: 81 \| Download: 603
15	Importance of comprehensive nutritional assessment in predicting survival in cirrhosis 5/27/2025 7:04:45 AM \| Browse: 38 \| Download: 107
16	Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis 4/25/2025 8:23:03 AM \| Browse: 95 \| Download: 431
17	Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions 4/18/2025 7:43:23 AM \| Browse: 165 \| Download: 518
18	Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients 3/26/2025 4:06:57 AM \| Browse: 98 \| Download: 627
19	Dysregulation of bile acid signal transduction causes neurological dysfunction in cirrhosis rats 3/26/2025 4:06:51 AM \| Browse: 84 \| Download: 580
20	Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis 2/20/2025 8:40:36 AM \| Browse: 108 \| Download: 417
21	Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt 2/20/2025 8:39:23 AM \| Browse: 100 \| Download: 456
22	Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis 1/6/2025 8:47:54 AM \| Browse: 101 \| Download: 616
23	Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications 12/20/2024 3:53:46 AM \| Browse: 157 \| Download: 688
24	Insights and future directions in studying intestinal microbiota post-transjugular intrahepatic portosystemic shunt for hepatitis B virus-related portal hypertension 11/13/2024 10:10:50 AM \| Browse: 155 \| Download: 532
25	Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy 11/6/2024 9:51:00 AM \| Browse: 156 \| Download: 555
26	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 146 \| Download: 572
27	Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit 10/31/2024 9:55:09 AM \| Browse: 157 \| Download: 660
28	Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension 8/13/2024 8:00:24 AM \| Browse: 147 \| Download: 905
29	Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension 7/22/2024 11:57:18 AM \| Browse: 134 \| Download: 947
30	Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective 5/22/2024 11:33:24 AM \| Browse: 130 \| Download: 554
31	Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment? 2/27/2024 11:58:45 AM \| Browse: 232 \| Download: 912
32	Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions 1/23/2024 9:31:44 AM \| Browse: 275 \| Download: 882
33	Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy 11/24/2023 6:10:12 AM \| Browse: 282 \| Download: 1047
34	Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt 8/25/2023 12:08:22 PM \| Browse: 252 \| Download: 873
35	Intracranial pressure monitoring in the perioperative period of patients with acute liver failure undergoing orthotopic liver transplantation 6/16/2023 7:59:37 AM \| Browse: 306 \| Download: 759
36	Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 5/16/2023 7:16:46 AM \| Browse: 288 \| Download: 823
37	Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt 5/11/2023 8:05:04 AM \| Browse: 443 \| Download: 1291
38	Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report 2/6/2023 6:38:44 AM \| Browse: 371 \| Download: 1130
39	Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report 10/21/2022 2:24:59 AM \| Browse: 481 \| Download: 1359
40	Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions 7/27/2022 2:48:53 AM \| Browse: 585 \| Download: 1433
41	Evidence-based approach to management of hepatic encephalopathy in adults 4/22/2022 10:52:23 AM \| Browse: 636 \| Download: 1207
42	Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment 3/24/2022 2:13:21 PM \| Browse: 655 \| Download: 2272
43	Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis 3/24/2022 2:13:21 PM \| Browse: 652 \| Download: 2250
44	Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report 2/23/2022 3:51:55 PM \| Browse: 531 \| Download: 1367
45	Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions 11/25/2021 7:42:46 AM \| Browse: 554 \| Download: 1067
46	Simultaneous embolization of spontaneous porto-systemic shunts and intrahepatic arterioportal fistula: A case report 10/29/2021 12:16:54 PM \| Browse: 645 \| Download: 1827
47	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 829 \| Download: 1913
48	Neurological and psychiatric effects of hepatitis C virus infection 8/4/2021 7:56:20 AM \| Browse: 836 \| Download: 1896
49	Long-term albumin infusion in decompensated cirrhosis: A review of current literature 4/16/2021 10:13:42 AM \| Browse: 740 \| Download: 1706
50	Comparative study of the indocyanine green-R15, Child-Pugh score and model for end-stage liver disease score for the prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 1/29/2021 7:57:41 AM \| Browse: 793 \| Download: 2108